Trial · NCT03555149
Adverse event totals24
The totals the trial posted for each group.
1 to 20 of 24
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Regorafenib (Control) | 18 | 24 |
| Total, all-cause mortality | Atezolizumab + Imprime PGG + Bevacizumab | 15 | 15 |
| Total, all-cause mortality | Atezolizumab + Isatuximab | 15 | 15 |
| Total, all-cause mortality | Atezolizumab + Selicrelumab + Bevacizumab | 4 | 6 |
| Total, all-cause mortality | Atezolizumab + Idasanutlin | 4 | 4 |
| Total, all-cause mortality | Atezolizumab + Regorafenib | 11 | 15 |
| Total, all-cause mortality | Atezolizumab + Regorafenib + AB928 | 12 | 15 |
| Total, all-cause mortality | Atezolizumab + LOAd703 | 1 | 2 |
| Total, other adverse events | Regorafenib (Control) | 19 | 19 |
| Total, other adverse events | Atezolizumab + Imprime PGG + Bevacizumab | 15 | 15 |
| Total, other adverse events | Atezolizumab + Isatuximab | 15 | 15 |
| Total, other adverse events | Atezolizumab + Selicrelumab + Bevacizumab | 6 | 6 |
| Total, other adverse events | Atezolizumab + Idasanutlin | 4 | 4 |
| Total, other adverse events | Atezolizumab + Regorafenib | 15 | 15 |
| Total, other adverse events | Atezolizumab + Regorafenib + AB928 | 15 | 15 |
| Total, other adverse events | Atezolizumab + LOAd703 | 2 | 2 |
| Total, serious adverse events | Regorafenib (Control) | 5 | 19 |
| Total, serious adverse events | Atezolizumab + Imprime PGG + Bevacizumab | 1 | 15 |
| Total, serious adverse events | Atezolizumab + Isatuximab | 5 | 15 |
| Total, serious adverse events | Atezolizumab + Selicrelumab + Bevacizumab | 3 | 6 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03555149/event-totals